James Mulay sold $1.1M of CG Oncology (CGON)

Executed Apr 17, disclosed Apr 20, 3 days later.

Value, as filed

$1.1M

15,600 sh × $73.01

Executed

Apr 17

the trade date, as filed

Disclosed

Apr 20

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JM James Mulay Director profile →

James Mulay (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in CG Oncology, Inc. (CGON). The largest single filing was $1.8M of CGON (24,165 sh × $75.16, as filed), executed Jul 10.

The name

CGON CG Oncology, Inc. CGON · Healthcare · 14 filings in 24 months ticker →

Healthcare · CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by James Mulay in CGON

CGONSALE CG Oncology, Inc. $1.8M
24,165 sh × $75.16
Exec Jul 10
Filed Jul 14 · 4:15 PM ET CGONSALE CG Oncology, Inc. $556K
10,491 sh × $52.99
Exec Jan 9
Filed Jan 13 · 5:30 PM ET CGONSALE CG Oncology, Inc. $260K
5,903 sh × $43.99
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET CGONSALE CG Oncology, Inc. $500K
12,755 sh × $39.19
Exec Sep 29 2025
Filed Sep 30 2025 · 5:30 PM ET CGONSALE CG Oncology, Inc. $885K
22,686 sh across 2 lots
Exec Sep 18 2025
Filed Sep 22 2025 · 5:30 PM ET CGONSALE CG Oncology, Inc. $852K
27,015 sh across 4 lots
Exec Sep 5 2025
Filed Sep 8 2025 · 5:30 PM ET